Respiratory Drugs Market Size

Respiratory Drugs Market size is predicted to reach USD 990 billion by the end of 2036, growing at a CAGR of 2% during the forecast period i.e., 2024-2036. In the year 2023, industry size of respiratory infection was over USD 200 billion. This market growth is set to be dominated by growing consumption of tobacco.

Further, the prevalence of second-hand smoke is also surging. For instance, as per the estimation of the World Health Organization, over 1.3 million non-smokers are killed due to the exposure of second-hand smoking across the globe. Second-hand smoking is the major driver for the rise in respiratory infection. As a result, the market is predicted to gather highest revenue.

Moreover, another main reasons for the rise in respiratory disease is upper respiratory infection. Upper respiratory tract infection occurs in a higher part of the respiratory tract. Nasal passages, sinuses, pharynx, and trachea are the specific areas that are most affected by the infection. The respiratory drugs are one of the common treatment available in the market. Hence, the market is poised to observe growth.